Report of five novel and one recurrent COL2A1 mutations with analysis of genotype-phenotype correlation in patients with a lethal type II collagen disorder
Gr. Mortier et al., Report of five novel and one recurrent COL2A1 mutations with analysis of genotype-phenotype correlation in patients with a lethal type II collagen disorder, J MED GENET, 37(4), 2000, pp. 263-271
Citations number
32
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Molecular Biology & Genetics
Achondrogenesis II-hypochondrogenesis and severe spondyloepiphyseal dysplas
ia congenita (SEDC) are lethal forms of dwarfism caused by dominant mutatio
ns in the type II collagen gene (COL2A1). To identify the underlying defect
in seven cases with this group of conditions, we used the combined strateg
y of cartilage protein analysis and COL2A1 mutation analysis. Overmodified
type II collagen and the presence of type I collagen was found in the carti
lage matrix of all seven cases. Five patients were heterozygous for a nucle
otide change that predicted a glycine substitution in the triple helical do
main (G313S, G517V, G571A, G910C, G943S). In an five cases, analysis of car
tilage type II collagen suggested incorporation of the abnormal al(II) chai
n in the extracellular collagen trimers. The G943S mutation has been report
ed previously in another unrelated patient with a strikingly similar phenot
ype, illustrating the possible specific effect of the mutation. The radiogr
aphically less severely affected patient was heterozygous for a 4 bp deleti
on in the splice donor site of intron 35, likely to result in aberrant spli
cing. One case was shown to be heterozygous for a single nucleotide change
predicted to result in a T1191N substitution in the carboxy-propeptide of t
he proal(II) collagen chain. Study of the clinical, radiographic, and morph
ological features of the seven cases supports evidence for a phenotypic con
tinuum between achondrogenesis II-hypochondrogenesis and lethal SEDC and su
ggests a relationship between the amount of type I collagen in the cartilag
e and the severity of the phenotype.